Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
In this issue
Drug safety advice
- Yasmin: update on risk of venous thromboembolism
- Clopidogrel and proton pump inhibitors: interaction - updated advice
- Intravenous zoledronic acid: adverse effects on renal function
- Parenteral amphotericin B: fatal overdose risk due to confusion between lipid-based and non-lipid-based formulations
- Rifadin infusion (rifampicin): new solvent formulation and changes to compatible diluents
Stop press
- Becaplermin (Regranex) for diabetic ulcers: contraindicated in patients with any known current cancer
Other information from the MHRA
- MHRA conference for doctors in training
- Patient information leaflet of the month: Methotrexate Tablets
Drug Safety Update: Volume 3, Issue 9, April 2010 
